Project Grant HT94252510492
Award Date
7/1/25
Completion Date
6/30/28
Dollars Obligated
$227K
Federal Agency
Defense Health Agency
Federal Grant Program
12.420
Assistance Type
Project Grant
Place of Performance
Birmingham, AL 35294, USA
Similar Awards
The University of Alabama at Birmingham (UAB) was awarded a $650,845 federal Project Grant from the Defense Health Agency under the Military Medical Research and Development (CFDA 12.420) program. The grant, awarded on July 1, 2025, will support UAB's research into developing macrophage-centric prognostic biomarkers for checkpoint blockade immunotherapy in melanoma. This research aims to transform healthcare for military service members and the broader public by advancing innovative approaches...
The University of Alabama at Birmingham (UAB) was awarded a $1,317,584 Project Grant from the Defense Health Agency under the Military Medical Research and Development (CFDA 12.420) federal grant program. The grant, with a performance period from July 1, 2025 to June 30, 2028, will support UAB's research on "Macrophage-Centric Prognostic Biomarkers for Checkpoint Blockade Immunotherapy in Melanoma." The project aims to develop innovative prognostic biomarkers and advance the...
The University of Alabama at Birmingham (UAB) was awarded a $733,662 Project Grant from the Defense Health Agency under the Military Medical Research and Development program (CFDA 12.420). The grant, awarded on September 1, 2024, supports research to investigate the role of tumor glycans in immune suppression. This federally funded project aims to advance scientific understanding of how specific carbohydrate molecules on tumor cells can inhibit the body's immune response, with the goal of...
This federal Project Grant award of $1,485,001.00, provided by the Defense Health Agency under the Military Medical Research and Development (CFDA 12.420) program, supports research conducted by the University of Alabama at Birmingham (UAB) to overcome perturbations that orchestrate immune exhaustion and dysfunction in breast cancer. The project aims to advance scientific understanding and develop innovative solutions in this critical area of biomedical research, with potential to transform...
The University of Alabama at Birmingham will receive $742,500 through a three-year Project Grant award from the Department of the Army Medical Command under the Military Medical Research and Development program. The grant will fund research from August 1, 2022 to July 31, 2025 to uncover and target the molecular mechanisms of tumor-intrinsic immunotherapeutic resistance in melanoma. The Military Medical Research and Development program, identified by CFDA #12.420, supports basic, applied, and...
The University of Alabama at Birmingham (UAB) received a $1,599,981.00 Project Grant award from the Defense Health Agency on June 1, 2024 under the Military Medical Research and Development program (CFDA 12.420). The grant supports research to activate immune reserves and prevent secondary bacterial lung infections after trauma and hemorrhage. This biomedical research project aims to improve health outcomes for military service members and the broader public. The project will be conducted over a...
This Project Grant award of $1,113,750.00 from the Defense Health Agency, under the Military Medical Research and Development program (CFDA 12.420), supports the University of Alabama at Birmingham (UAB) in developing "DUAL CD24/CD276 TARGETING THERAPIES FOR TRIPLE-NEGATIVE BREAST CANCER." The 3-year award, running from August 1, 2023 to July 31, 2026, will fund research to investigate medical solutions for the battlefield and transform health care for service members and the public...
This Project Grant award of $1,177,716.00 from the Defense Health Agency, under the Military Medical Research and Development program (CFDA 12.420), supports research at the University of Alabama at Birmingham (UAB) to investigate the "Metabolic Regulation of Metastatic Potential Through mRNA Translation." The award, which began on July 15, 2024 and will run through July 14, 2028, aims to advance scientific understanding of cancer metastasis through the study of metabolic processes and...
This federal Project Grant award of $220,326.00, awarded by the Defense Health Agency under the Military Medical Research and Development (CFDA 12.420) program, supports research at the University of Alabama at Birmingham (UAB) to develop novel, selective PARP protein degraders for prostate cancer treatment utilizing PSMA uptake enhancement. The award period is from April 1, 2025 to March 31, 2027. UAB, a leading academic medical center with extensive biomedical research capabilities, will...
The University of Alabama at Birmingham (UAB) was awarded a $1,485,000.00 Project Grant from the Defense Health Agency under the Military Medical Research and Development program (CFDA 12.420) to improve the oncolytic immunovirotherapy of malignant glioma by targeting the glioma secretome. The 3-year grant was awarded on September 30, 2023 and is set to conclude on September 29, 2026. UAB is a public research university known for its innovative and interdisciplinary approach to education, and it...